Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61083 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL8681308 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL5960763 | 0.75 | — | — | |
| SCHEMBL61974 | 0.75 | — | — | |
| SCHEMBL61735 | 0.75 | — | — | |
| SCHEMBL60474 | 0.73 | TSHR (0.32) | — | |
| Hydrochloric Acid SCHEMBL3168559 | 0.73 | — | — | |
| SCHEMBL61654 | 0.73 | TSHR (0.32) | — | |
| SCHEMBL62222 | 0.73 | TSHR (0.32) | — | |
| Hydrochloric Acid SCHEMBL29152267 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109563135-B | Alpha (V) beta (6) integrin binding peptides and methods of use thereof | 加利福尼亚大学董事会 | 2024-01-23 | — | — | CN | disclosed |
| US-20230346960-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-02 | — | — | US | disclosed |
| US-11612663-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-28 | — | — | US | disclosed |
| US-11246961-B2 | Engineered scaffolds for vascularized tissue repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-15 | — | — | US | disclosed |
| EP-3426700-B1 | ENGINEERED SCAFFOLDS FOR VASCULARIZED TISSUE REPAIR | UNIV CALIFORNIA (US) | 2021-12-15 | — | — | EP | disclosed |
| CN-106573031-B | Double-ended pegylated integrin-binding peptides and methods of use thereof | 加利福尼亚大学董事会 | 2021-05-28 | — | — | CN | disclosed |
| CN-112672747-A | Peptides for activating cell signalling in osteoprogenitor cells | 加利福尼亚大学董事会 | 2021-04-16 | — | — | CN | disclosed |
| US-20210093728-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-04-01 | — | — | US | disclosed |
| EP-3280723-B1 | BACKBONE-CYCLIZED PEPTIDOMIMETICS | POLYPHOR AG (CH) | 2021-01-06 | — | — | EP | disclosed |
| US-10730911-B2 | Backbone-cyclized peptidomimetics with GLP-1R modulating activity | UNIVERSITAT ZURICH (CH) | 2020-08-04 | — | — | US | disclosed |
| US-20160017000-A1 | RGD-CONTAINING CYCLIC PEPTIDES | UNIV CALIFORNIA (US) | 2016-01-21 | — | — | US | disclosed |
| US-9180395-B2 | Porous thin films | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-11-10 | — | — | US | disclosed |
| US-8754038-B2 | Template-fixed peptidomimetics with CCR10 antagonistic activity | POLYPHOR AG (CH) | 2014-06-17 | — | — | US | disclosed |
| US-20130129972-A1 | Porous Thin Films | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-05-23 | — | — | US | disclosed |
| US-20120283168-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY | POLYPHOR AG (CH) | 2012-11-08 | — | — | US | disclosed |
| EP-2501715-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVTY | Polyphor Ag (CH) | 2012-09-26 | — | — | EP | disclosed |
| WO-2011079015-A1 | RGD-CONTAINING CYCLIC PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011060832-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY | POLYPHOR AG (CH) | 2011-05-26 | — | — | WO | disclosed |
| WO-2011060937-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVTY | POLYPHOR AG (CH) | 2011-05-26 | — | — | WO | disclosed |
| WO-2011060229-A1 | POROUS THIN FILMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10730911-B2 | Backbone-cyclized peptidomimetics with GLP-1R modulating activity | GLP1R, GIPR, SSTR1 | MEN1 645/4885CYP2C9 2864/4885KMT2A 3930/4885 |
| US-20230346960-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, PDGFRB, TEK | MEN1 4811/4885CYP2C9 4598/4885KMT2A 4334/4885 |
| US-20120283168-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY | CCR10, CCR1, CCRL2 | MEN1 3852/4885CYP2C9 3612/4885KMT2A 3431/4885 |
| US-20210093728-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, PDGFRB, TEK | MEN1 4811/4885CYP2C9 4598/4885KMT2A 4334/4885 |
| US-11246961-B2 | Engineered scaffolds for vascularized tissue repair | FLT4, FLT1, KDR | MEN1 2992/4885CYP2C9 4415/4885KMT2A 4128/4885 |
| US-11612663-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | PDGFA, PDGFRB, TEK | MEN1 4811/4885CYP2C9 4598/4885KMT2A 4334/4885 |
| US-20160017000-A1 | RGD-CONTAINING CYCLIC PEPTIDES | ITGAV, ITGB3, ITGAL | MEN1 3074/4885CYP2C9 4552/4885KMT2A 4670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.